Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Opioids and Vitamin C: Known Interactions and Potential for Redox-Signaling Crosstalk. | Antioxidants (Basel) | 2022 | 35883757 | PubTator, text mining | PubMed |
| Epigenetics in drug disposition & drug therapy: symposium report of the 24th North American meeting of the International Society for the Study of Xenobiotics (ISSX). | Drug Metab Rev | 2022 | 35876105 | PubTator, text mining | PubMed |
| Phloretin exhibits potential food-drug interactions by inhibiting human UDP-glucuronosyltransferases in vitro. | Toxicol In Vitro | 2022 | 35868516 | PubTator, text mining | PubMed |
| Association of Physical Activity With Bioactive Lipids and Cardiovascular Events. | Circ Res | 2022 | 35862024 | PubTator, text mining | PubMed |
| Polyadenylation ligation-mediated sequencing (PALM-Seq) characterizes cell-free coding and non-coding RNAs in human biofluids. | Clin Transl Med | 2022 | 35858042 | PubTator, text mining | PubMed |
| Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing. | Front Pharmacol | 2022 | 35846994 | PubTator, text mining | PubMed |
| Interactions of the protease inhibitor, ritonavir, with common anesthesia drugs. | Paediatr Anaesth | 2022 | 35842922 | PubTator, text mining | PubMed |
| Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response. | Pharmacopsychiatry | 2022 | 35839823 | PubTator, text mining | PubMed |
| The Pharmacogenetics of Opiates and Its Impact on Delirium in Mechanically Ventilated Adults: A Pilot Study. | J Pharm Technol | 2022 | 35832565 | PubTator, text mining | PubMed |
| Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information. | NPJ Digit Med | 2022 | 35817846 | PubTator, text mining | PubMed |
| Biotransformation novel advances - 2021 year in review. | Drug Metab Rev | 2022 | 35815654 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| UGT1A1 and UGT1A9 Are Responsible for Phase II Metabolism of Tectorigenin and Irigenin In Vitro. | Molecules | 2022 | 35807350 | PubTator, text mining | PubMed |
| Complete Reaction Phenotyping of Propranolol and 4-Hydroxypropranolol with the 19 Enzymes of the Human UGT1 and UGT2 Families. | Int J Mol Sci | 2022 | 35806479 | PubTator, text mining | PubMed |
| The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review. | Pharmgenomics Pers Med | 2022 | 35795337 | PubTator, text mining | PubMed |
| Highly perturbed genes and hub genes associated with type 2 diabetes in different tissues of adult humans: a bioinformatics analytic workflow. | Funct Integr Genomics | 2022 | 35788821 | PubTator, text mining | PubMed |
| Estetrol/Drospirenone: A Review in Oral Contraception. | Drugs | 2022 | 35781795 | PubTator, text mining | PubMed |
| Transporter-Enzyme Interplay in the Pharmacokinetics of PF-06835919, A First-in-class Ketohexokinase Inhibitor for Metabolic Disorders and Non-alcoholic Fatty Liver Disease. | Drug Metab Dispos | 2022 | 35779864 | PubTator, text mining | PubMed |
| The pharmacogenetics of mycophenolate mofetil in Tunisian renal transplant patients. | Per Med | 2022 | 35770851 | PubTator, text mining | PubMed |
| Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective. | Pharmgenomics Pers Med | 2022 | 35761855 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=20